These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 32892505)

  • 1. Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.
    White D; MacDonald S; Edwards T; Bridgeman C; Hayman M; Sharp M; Cox-Morton S; Duff E; Mahajan S; Moore C; Kirk M; Williams R; Besser M; Thomas W
    Int J Lab Hematol; 2021 Feb; 43(1):123-130. PubMed ID: 32892505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19-related laboratory coagulation findings.
    Devreese KMJ
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):36-42. PubMed ID: 34288440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study.
    Hardy M; Michaux I; Lessire S; Douxfils J; Dogné JM; Bareille M; Horlait G; Bulpa P; Chapelle C; Laporte S; Testa S; Jacqmin H; Lecompte T; Dive A; Mullier F
    Thromb Res; 2021 Jan; 197():20-23. PubMed ID: 33161283
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.
    Ahmed S; Zimba O; Gasparyan AY
    Clin Rheumatol; 2020 Sep; 39(9):2529-2543. PubMed ID: 32654082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability.
    van de Berg TW; Hulshof AM; Nagy M; van Oerle R; Sels JW; van Bussel B; Ten Cate H; Henskens Y; Spronk HMH;
    Thromb Res; 2021 May; 201():84-89. PubMed ID: 33662799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
    Tschopl M; Tsakiris DA; Marbet GA; Labs KH; Jäger K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3208-14. PubMed ID: 9409313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired fibrinolysis in critically ill COVID-19 patients.
    Bachler M; Bösch J; Stürzel DP; Hell T; Giebl A; Ströhle M; Klein SJ; Schäfer V; Lehner GF; Joannidis M; Thomé C; Fries D
    Br J Anaesth; 2021 Mar; 126(3):590-598. PubMed ID: 33422287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation and coagulopathy - an ominous duo in COVID19.
    Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
    Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19).
    Salamanna F; Maglio M; Landini MP; Fini M
    Platelets; 2020 Jul; 31(5):627-632. PubMed ID: 32397915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus-induced coagulopathy during the course of disease.
    Friedrich MS; Studt JD; Braun J; Spahn DR; Kaserer A
    PLoS One; 2020; 15(12):e0243409. PubMed ID: 33332362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients.
    de la Morena-Barrio ME; Bravo-Pérez C; Miñano A; de la Morena-Barrio B; Fernandez-Perez MP; Bernal E; Gómez-Verdu JM; Herranz MT; Vicente V; Corral J; Lozano ML
    Sci Rep; 2021 Apr; 11(1):7792. PubMed ID: 33833254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis.
    Kelliher S; Weiss L; Cullivan S; O'Rourke E; Murphy CA; Toolan S; Lennon Á; Szklanna PB; Comer SP; Macleod H; Le Chevillier A; Gaine S; O'Reilly KMA; McCullagh B; Stack J; Maguire PB; Ní Áinle F; Kevane B
    J Thromb Haemost; 2022 Apr; 20(4):1008-1014. PubMed ID: 35102689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic System (Fibrinogen Level, D-Dimer, and FDP) in Severe and Non-Severe Patients With COVID-19: A Systematic Review and Meta-Analysis.
    Rostami M; Khoshnegah Z; Mansouritorghabeh H
    Clin Appl Thromb Hemost; 2021; 27():10760296211010973. PubMed ID: 34933579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis.
    Nougier C; Benoit R; Simon M; Desmurs-Clavel H; Marcotte G; Argaud L; David JS; Bonnet A; Negrier C; Dargaud Y
    J Thromb Haemost; 2020 Sep; 18(9):2215-2219. PubMed ID: 32668058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The haemostatic profile in critically ill COVID-19 patients receiving therapeutic anticoagulant therapy: An observational study.
    Tsantes AE; Frantzeskaki F; Tsantes AG; Rapti E; Rizos M; Kokoris SI; Paramythiotou E; Katsadiotis G; Karali V; Flevari A; Chrysanthopoulou E; Maratou E; Kyriakou E; Gialeraki A; Bonovas S; Dimopoulos G; Tsangaris I; Armaganidis A
    Medicine (Baltimore); 2020 Nov; 99(47):e23365. PubMed ID: 33217881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prothrombotic State in Patients With a Left Atrial Appendage Thrombus of Unknown Origin and Cerebrovascular Events.
    Meus R; Son M; Sobczyk D; Undas A
    Stroke; 2016 Jul; 47(7):1872-8. PubMed ID: 27301942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of D-dimer, Weight, and Renal Function-Adjusted Thromboprophylaxis in Patients with Coronavirus Disease 2019 (COVID-19).
    Arachchillage DRJ; Shi C; Saliu D; Kozman P; Mi E; Buti N; Kashef E; Copley SJ; Gomez C; Leonard R; Aziz R; Shlebak AA; Laffan M
    Semin Thromb Hemost; 2021 Jun; 47(4):436-441. PubMed ID: 33482676
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 and Sepsis Are Associated With Different Abnormalities in Plasma Procoagulant and Fibrinolytic Activity.
    Bouck EG; Denorme F; Holle LA; Middelton EA; Blair AM; de Laat B; Schiffman JD; Yost CC; Rondina MT; Wolberg AS; Campbell RA
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):401-414. PubMed ID: 33196292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Spike Proteins and Cell-Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis.
    Bhargavan B; Kanmogne GD
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercoagulable viscoelastic blood clot characteristics in critically ill coronavirus disease 2019 patients and associations with thrombotic complications.
    Roh DJ; Eiseman K; Kirsch H; Yoh N; Boehme A; Agarwal S; Park S; Connolly ES; Claassen J; Wagener G
    J Trauma Acute Care Surg; 2021 Jan; 90(1):e7-e12. PubMed ID: 33009340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.